Wellcome, which has substantial interests in Cambridge, has awarded £5.3 million to Wysa to fund a scale-up study that will adapt a clinically validated digital mental health intervention for ...

AstraZeneca, which has just launched on the New York Stock Exchange in addition to its London and Stockholm listings, is ...

Marshall Aerospace and Nordiq Products have begun an industrial cooperation project to support the development and path to ...

Law firm Howes Percival has confirmed its Milton Keynes office will move to The Pinnacle on Midsummer Boulevard in April from ...

Three of the four winners in the latest Trinity Bradfield Prize in Cambridge were CleanTech plays and the fourth has eco ...

Cambridge headquartered life science giant AstraZeneca has made a sensational bow on Wall Street, opening at $187.50 a share and soon sailing past $191.22p for an intra-day market cap of $591.712 ...

As part of its plan to implement last year’s Keep Britain Working Report, the Government is re-vamping the Disability ...

A $5.3 billion deal that sent interest soaring in the AI global cyber security sector just 15 months ago when Thoma Bravo in the US bought Cambridge's Darktrace, has already thrown up an issue over ...

The UK biotech sector continues to demonstrate a quiet but determined resilience, even as investors navigate more cautious ...

The life sciences outlook for 2026 is being shaped by three interlocking forces, writes Paul Hughes, Managing Director, Life ...

The global power and potential of Cambridge’s Granta Park as an influencer of life science innovation is highlighted in new ...

Mayor Andy Burnham, who has just lost his fight to leave his role and become an MP in an upcoming by-election, has got back to business in rapid time by backing the expansion locally of Vortex Biotech ...